Erratum: SC83288 is a clinical development candidate for the treatment of severe malaria

Pegoraro, S. et al. (2017) Erratum: SC83288 is a clinical development candidate for the treatment of severe malaria. Nature Communications, 8(1), 15273. (doi: 10.1038/ncomms15273) (PMID:28383016) (PMCID:PMC5384206)

[img]
Preview
Text
203728.pdf - Published Version
Available under License Creative Commons Attribution.

485kB

Abstract

No abstract available.

Item Type:Articles (Erratum)
Additional Information:Original article: http://eprints.gla.ac.uk/147978/
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Otto, Dr Thomas
Authors: Pegoraro, S., Duffey, M., Otto, T. D., Wang, Y., Rösemann, R., Baumgartner, R., Fehler, S. K., Lucantoni, L., Avery, V. M., Moreno-Sabater, A., Mazier, D., Vial, H. J., Strobl, S., Sanchez, C. P., and Lanzer, M.
College/School:College of Medical Veterinary and Life Sciences > Institute of Infection Immunity and Inflammation
Journal Name:Nature Communications
Publisher:Nature Publishing Group
ISSN:2041-1723
ISSN (Online):2041-1723
Copyright Holders:Copyright © 2017 The Authors
First Published:First published in Nature Communications 8(1):15273
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record